Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Mechanism of Action of N-acetylcysteine for Reducing the Risk of Infection in Alcoholic Hepatitis

NCT03069300 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03069300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03069300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Mechanism of Action of N-acetylcysteine for Reducing the Risk of Infection in Alcoholic Hepatitis
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2015
Completion date
June 1, 2025
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis, infection